Molecular and Clinical Oncology

Second malignancies after breast cancer: The impact of adjuvant therapy (Review)
pp. 331-336(6)
Authors: Dong; Chen

Oral mucositis in cancer treatment: Natural history, prevention and treatment (Review)
pp. 337-340(4)
Authors: da Cruz Campos; Neiva Campos; Monteiro Aarestrup; Vieira Aarestrup

Clinical applications of nucleic acid aptamers in cancer (Review)
pp. 341-348(8)
Authors: Pei; Zhang; Liu

Contribution of diuretic therapy with human serum albumin to the management of ascites in patients with advanced liver cirrhosis: A prospective cohort study
pp. 349-355(7)
Authors: Nakamura; Sata; Hiroishi; Masaki; Moriwaki; Murawaki; Yatsuhashi; Fujiyama; Imawari

KRAS mutation in patients with metastatic colorectal cancer does not preclude benefit from oxaliplatin or irinotecanbased treatment
pp. 356-362(7)
Authors: Soeda; Shimodaira; Watanabe; Suzuki; Gamo; Takahashi; Komine; Kato; Ishioka

Clinicopathological characteristics of vascular endothelial growth factor expression in uveal melanoma: A metaanalysis
pp. 363-368(6)
Authors: Yang; Kuang; Pan; Tan; Lu; Lu; Cheng; Li

En bloc vascular resection for the treatment of borderline resectable pancreatic head carcinoma
pp. 369-374(6)
Authors: Kitagawa; Tajima; Nakagawara; Makino; Miyashita; Shoji; Nakanuma; Hayashi; Takamura; Ohta; Ohtake

Palonosetron exhibits higher total control rate compared to firstgeneration serotonin antagonists and improves appetite in delayedphase chemotherapyinduced nausea and vomiting
pp. 375-379(5)
Authors: Ueda; Shimono; Nishimura; Shimamoto; Yamaue

Combined therapeutic efficacy of 188Reliposomes and sorafenib in an experimental colorectal cancer liver metastasis model by intrasplenic injection of C26luc murine colon cancer cells
pp. 380-384(5)
Authors: Chang; Hsu; Chang; Lan; Ting; Lee

Alternative endpoints to the 5year overall survival and locoregional control for nasopharyngeal carcinoma: A retrospective analysis of 2,450 patients
pp. 385-392(8)
Authors: Chen; Yi; Gao; Li; Shen; Li; Tu; Tao; Jiang; Xia

Clinical characteristics and prognostic factors for advanced hepatocellular carcinoma with extrahepatic metastasis
pp. 393-398(6)
Authors: Aino; Sumie; Niizeki; Kuromatsu; Tajiri; Nakano; Satani; Yamada; Okamura; Shimose; Sumie; Torimura; Sata

Hyperthermic intraperitoneal chemotherapy with mitomycin C and 5fluorouracil in patients at high risk of peritoneal metastasis from colorectal cancer: A preliminary clinical study
pp. 399-404(6)
Authors: Shimizu; Murata; Sonoda; Mekata; Ohta; Takebayashi; Miyake; Tani

Phase II study of concurrent chemoradiotherapy with carboplatin and vinorelbine for locally advanced non-small-cell lung cancer
pp. 405-410(6)
Authors: Ishida; Hirose; Yokouchi; Oki; Kusumoto; Sugiyama; Ishida; Shirai; Nakashima; Yamaoka; Ohnishi; Ohmori; Kagami

Prognostic significance of Bcell lymphoma 2 expression in acute leukemia: A systematic review and metaanalysis
pp. 411-414(4)
Authors: Liu; He; Liu; Shi; Zhu; Cheng; Zhao; Wang; Zhang

Magnetic resonance characteristics of adultonset LhermitteDuclos disease: An indicator for active cancer surveillance?
pp. 415-420(6)
Authors: Wei; Zhang; Li; Kang; Zhao; Liu; Tang; Wu; Han; Yin

Elastofibroma dorsi: Surgical indications and complications of a rare soft tissue tumor
pp. 421-424(4)
Authors: Nagano; Yokouchi; Setoyama; Sasaki; Shimada; Kawamura; Ishidou; Setoguchi; Komiya

Expression and clinical significance of girdin in gastric cancer
pp. 425-428(4)
Authors: Wang; Lin; Li; Wang

effects of smoking and alcohol consumption on 5-fluorouracilrelated metabolic enzymes in oral squamous cell carcinoma
pp. 429-434(6)
Authors: Yamashita; Kato; Long; Makita; Yonemoto; Iida; Tamaoki; Hatakeyama; Shibata

Nextgeneration sequencing of BRCA1 and BRCA2 in breast cancer patients and control subjects
pp. 435-439(5)
Authors: Balabanski; Antov; Dimova; Ivanov; Nacheva; Gavrilov; Nesheva; Rukova; Hadjidekova; Malinov; Toncheva

Results on efficacy and safety of cancer treatment with or without tumor necrosis factorrelated apoptosisinducing ligandrelated agents: a meta-analysis
pp. 440-448(9)
Authors: Sun; Li; Sun; Yang; Mei; Ouyang; Yang; Xie

Erlotinib with pemetrexed/cisplatin for patients with EGFR wild-type lung adenocarcinoma with brain metastases
pp. 449-453(5)
Authors: Zhang; Yang; Yang; Deng; Zhao; Xu; He

Weekly administration of paclitaxel and carboplatin with concurrent thoracic radiation in previously untreated elderly patients with locally advanced nonsmallcell lung cancer: A case series of 20 patients
pp. 454-460(7)
Authors: Takeshita; Masago; Fujita; Hata; Kaji; Kawamura; Tamai; Matsumoto; Nagata; Otsuka; Nakagawa; Otsuka; Tomii; Shintani; Takayama; Kokubo; Katakami

Experimental study on Qizhu formula for modulating survivin, an inhibitor of apoptosis, in MGC-803 gastric cancer cells
pp. 461-465(5)
Authors: Wen; Wang; Shan

Safety and continuity of second and thirdline therapy with paclitaxel or irinotecan for advanced and recurrent gastric cancer
pp. 466-472(7)
Authors: Kimura; Usami; Kanematsu; Iwai; Yoshimura; Mori; Sugiyama; Teramachi

Anthracyclinebased induction chemotherapy followed by concurrent cyclophosphamide, methotrexate and 5fluorouracil and radiation therapy in surgically resected axillary nodepositive breast cancer
pp. 473-478(6)
Authors: Recchia; Candeloro; Cesta; Di Staso; Bonfili; Gravina; Di Cesare; Necozione; Rea

Expression of ribonucleoside reductase subunit M1, but not excision repair crosscomplementation group 1, is predictive in muscleinvasive bladder cancer treated with chemotherapy and radiation
pp. 479-487(9)
Authors: Shilkrut; Wu; Thomas; Hamstra